Embolic Protection Devices Market
Embolic protection devices are catheter-shaped devices used to remove debris and extra material during the stenting procedure. These devices contain imaging devices that are used to locate debris. They are generally used when the debris is in the saphenous vein apart from being used in the percutaneous cardiac procedure.
According to the NCBI, in the last 10 years, about 400,000 people worldwide have undergone TAVR procedure, and this number is expected to grow at a rate of 40% annually. This rise in the number of patients suffering from TAVR is likely to contributing toward the global embolic protection devices market growth in the future. According to the World Health Organization, about 18 million people across the world suffer from cardiovascular disease annually, which accounts for about 31% of the total global deaths. The rise in the number of people suffering from cardiovascular diseases is anticipated to further fuel the growth of the embolic protection devices market. The growing awareness about minimally invasive procedures, product launches by companies in developing regions, and growing support by the government for treatment of chronic diseases are also anticipated to fuel the market for embolic protection devices in the future.
The global embolic protection devices market is divided into the application, material, type, indication, and end-user. By type, the market for embolic protection devices is segmented into proximal occlusion devices, distal occlusion devices, and distal filter devices. Distal filter devices are projected to dominate the market over the forecast time period. Based on material, the embolic protection devices market is segmented into nitinol and polyurethane. The Nitinol segment has highly specific properties that are required in embolic protection devices, which, in turn, is likely to fuel this segment in the future. By application, the market is segmented into the peripheral disease, neurovascular disease, and cardiovascular diseases. Neurovascular diseases are anticipated to show the highest growth rate in the upcoming years owing to the growing disease awareness. The indication segment of the market is divided into transcatheter aortic valve replacement, saphenous vein graft disease, percutaneous coronary intervention, carotid artery disease, and others. In 2017, the percutaneous coronary intervention segment dominated the market due to the increasing demand for minimally invasive procedures to treat these disorders. Based on end-user, the market is segmented ambulatory care centers, hospitals, and others. Hospitals are anticipated to dominate the global embolic protection devices market in the future.
By region, North America is anticipated to dominate the global embolic protection devices market in the upcoming years owing to the increase in the occurrences of cardiovascular disease and rising demand for minimally invasive procedures. The Asia Pacific embolic protection devices market is projected to show the highest growth rate over the forecast time period owing to the prevalence of cardiovascular diseases due to changes in lifestyle, product launches by major companies, raising awareness about the use of embolic protection devices among the surgeons, and increasing investments made by the government for the development of healthcare infrastructure.
Some key players of the global embolic protection devices market are Abbott, W.L. Gore & Associates, Boston Scientific, Allium Medical, Cordis, Medtronic, Contego Medical, Silk Road Medical, AngioSlide, and Claret Medical, among others.